Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2012
06/14/2012WO2012078906A2 Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
06/14/2012WO2012078863A2 Sample analysis system
06/14/2012WO2012078819A2 Apparatus, method and computer-accessible medium for noninvasive determination of electrical properties of tissues and materials
06/14/2012WO2012078813A2 Novel modulators and methods of use
06/14/2012WO2012078793A2 Methods and compositions related to tazarotene-induced gene 1 (tig1)
06/14/2012WO2012078717A1 Biomarkers for breast cancer patients
06/14/2012WO2012078648A2 Novel method of cancer diagnosis and prognosis and prediction of response to therapy
06/14/2012WO2012078623A2 Biomarkers for monitoring treatment of neuropsychiatric diseases
06/14/2012WO2012078602A2 Method for diagnosis and method of treatment of autism spectrum disorders and intellectual disability
06/14/2012WO2012078502A2 Biomarker test for acute coronary syndrome
06/14/2012WO2012078442A1 Methods for identifying high fouling hydrocarbon and for mitigating fouling of process equipment
06/14/2012WO2012078365A2 Biomarkers for prediction of breast cancer
06/14/2012WO2012078327A2 Fluid system health monitor
06/14/2012WO2012078313A2 Gb1 peptidic libraries and compounds, and methods of screening the same
06/14/2012WO2012078308A1 Devices and methods for concentration and analysis of fluids
06/14/2012WO2012078270A2 Efficient and effective supplement screening for the development of chemically defined media in cell culture
06/14/2012WO2012078260A1 Devices and washes for biomarker stabilization
06/14/2012WO2012078226A1 System and method for declustering well log samples
06/14/2012WO2012078138A1 Cell array quality control device for pathological analysis
06/14/2012WO2012078104A1 Cellulose substrates, compositions and methods for storage and analysis of biological materials
06/14/2012WO2012078066A2 Process for the deposition of biomaterials on water repellent substrates and resulting biomaterials
06/14/2012WO2012078053A1 Novel marker for detection of bladder cancer and/or inflammatory conditions of the bladder
06/14/2012WO2012077983A2 Bladder cancer diagnosis composition containing ape1/ref-1 and bladder cancer diagnosis kit using same
06/14/2012WO2012077933A2 Urine collecting device for a toilet seat-mounted urinalysis system
06/14/2012WO2012077898A2 Metabolic diseases-related odorant receptor genes and use thereof
06/14/2012WO2012077756A1 Device and method for detecting substance of interest utilizing metal-nanoparticles-accumulated structure
06/14/2012WO2012077737A1 Anti-psk polyclonal antibody, psk immunological analysis method using same, and psk immunological analysis kit
06/14/2012WO2012077716A1 Rubber analysis method
06/14/2012WO2012077643A1 IMMUNOLOGICAL cofilin-1 PROTEIN MEASUREMENT METHOD
06/14/2012WO2012077357A1 Assay chip
06/14/2012WO2012077325A1 Silicon structure, array substrate using same, and method for producing silicon structure
06/14/2012WO2012077324A1 Biochip and array substrate using same
06/14/2012WO2012077139A1 Method for the diagnosis of a carcinoma and uses thereof
06/14/2012WO2012077110A2 Methods and kits for detection of drugs
06/14/2012WO2012077097A1 Immunoassay for thrombin detection
06/14/2012WO2012077087A1 Nmr-based method with hr-mas probe on intact cells
06/14/2012WO2012077080A1 Compositions for separation methods
06/14/2012WO2012076935A1 Method and device using optical fibres for monitoring the concrete curing process
06/14/2012WO2012076883A1 Anti ccr4 antibodies and uses thereof
06/14/2012WO2012076812A1 Method and case for the in vitro diagnosis of prostate cancer
06/14/2012WO2012076729A2 Method for staging cancer progression by afm
06/14/2012WO2012076723A1 Method and marker for the diagnosis of a bile duct stricture and of a cholangiocellular carcinoma in bile
06/14/2012WO2012076722A1 Biomarkers for the diagnosis of multiple sclerosis
06/14/2012WO2012076679A1 Use of dronedarone for the preparation of a drug for use in the management of the risk of liver injury
06/14/2012WO2012076650A1 Marker for carcinoma
06/14/2012WO2012076623A1 A method to quantify the amount of a biological substance in a sample and a kit for performing the method
06/14/2012WO2012076614A2 Apparatus and method for the collection of samples of exhaled air
06/14/2012WO2012076582A1 Agtr1 as a marker for bevacizumab combination therapies
06/14/2012WO2012076553A2 Biomarkers and parameters for hypertensive disorders of pregnancy
06/14/2012WO2012076474A1 Method and device for determining the water content of non-water-based liquids
06/14/2012WO2012076137A2 Consumable for measuring an analyte concentration of a body fluid sample, reader for reading an optical data storage of such a consumable and measuring system
06/14/2012WO2012076020A1 A method for generating, storing, transporting, eluting and detecting clinical relevant information in plasma using filter paper
06/14/2012WO2012076010A1 Combined histological stain
06/14/2012WO2012075644A1 Method for manufacturing fluid-detecting test piece
06/14/2012WO2012075636A1 Tags of epigenetic modification for predicting differential potential of stem cells
06/14/2012WO2012075591A1 In vitro mitochondrial function test (mft) and uses thereof
06/14/2012WO2012061797A3 On-chip 4d lightfield microscope
06/14/2012WO2012054121A9 Silk-based biophotonic sensors
06/14/2012WO2012052629A3 Cyclin-a2 as a tumorigenesis biomarker and uses for obtaining anti-metastatic compounds
06/14/2012WO2012051290A3 Device for predicting gloss of low gloss coating by wet color measurement
06/14/2012WO2012044992A3 Methods and reagents for detection and treatment of esophageal metaplasia
06/14/2012WO2012044933A3 B and t lymphocyte attenuator marker for use in adoptive t-cell therapy
06/14/2012WO2012040615A3 Automated wood species identification
06/14/2012WO2012040439A3 Gas exchange system flow configuration
06/14/2012WO2012040264A3 Diagnostic tests for immune reactivity with human endothelial cell growth factor
06/14/2012WO2012040246A3 Biomarkers for growth hormone action
06/14/2012WO2012040073A3 Biomarkers of renal injury
06/14/2012WO2012037937A3 Method for detecting, differentiating, and quantifying t cell populations by means of reverse transcription quantitative real-time pcr (rt-qpcr) technology
06/14/2012WO2012037266A3 Using blood clot in microfluidic valving applications
06/14/2012WO2012034117A3 Enzyme co-factor enhancement of biosensor performance
06/14/2012WO2012033842A3 Methods, apparatuses and systems for collection of tissue sections
06/14/2012WO2012033666A3 Electronic and fluidic interface
06/14/2012WO2012033291A3 Apparatus for separating fine particles using magnetophoresis, and method for separating fine particles using same
06/14/2012WO2012027747A3 Asynchronous magnetic bead rotation sensing systems and methods
06/14/2012WO2012015765A3 Method for using gene expression to determine prognosis of prostate cancer
06/14/2012WO2012012714A3 Methods of detecting neurological or neuropsychiatric diseases or conditions
06/14/2012WO2012012694A3 Methods of detecting autoimmune or immune-related diseases or conditions
06/14/2012WO2012012693A3 Methods for detecting signatures of disease or conditions in bodily fluids
06/14/2012WO2012002775A4 Asthma diagnosis using the neuropilin-1 gene, and method for screening for a therapeutic agent for asthma
06/14/2012WO2011163320A3 Method and apparatus for detecting and regulating vascular endothelial growth factor (vegf) by forming a homeostatic loop employing a half-antibody biosensor
06/14/2012WO2011050384A9 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection
06/14/2012US20120151612 Non-surgical approach to prevent and correct craniofacial malformations during development
06/14/2012US20120150451 Optical Computation Fluid Analysis System and Method
06/14/2012US20120150448 Modular Analyte Measurement Systems, Modular Components Thereof and Related Methods
06/14/2012US20120150032 Sequence Variants Associated with Prostate Specific Antigen Levels
06/14/2012US20120150006 Stimuli responsive membrane
06/14/2012US20120149999 Tissue penetration device
06/14/2012US20120149883 Detection and quantification of modified proteins
06/14/2012US20120149765 Sgk1 as diagnostic and therapeutic target
06/14/2012US20120149762 Gene and Protein Relating to Hepatocellular Carcinoma and Methods of Use Thereof
06/14/2012US20120149714 Effects of Inhibitors of FGFR3 on Gene Transcription
06/14/2012US20120149668 Glucocorticoid receptor alleles and uses thereof
06/14/2012US20120149647 Methods for Assessing the Efficacy of Gemcitabine or Ara-C Treatment of Cancer Using Human Antigen R Levels
06/14/2012US20120149645 Compositions and modulation of myocyte enhancer factor 2 (mef2)
06/14/2012US20120149597 Protein fragment complementation assays for high-throughput and high-content screening
06/14/2012US20120149596 Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein b ratios
06/14/2012US20120149594 Biomarkers for prediction of breast cancer
06/14/2012US20120149132 Analyzer and analyzing method
06/14/2012US20120149131 Procalcitonin for the prognosis of adverse events
06/14/2012US20120149130 Polypeptides for the in vitro assessment of the sensitising potential of a test compound
1 ... 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 ... 3937